• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Meg Burton
Meg Burton
Meg Burton

Meg Burton

Senior Counsel

  • London UK
  • San Francisco USA
Contact Me Today
+44 20 7300 7000
vCard
Email me Call me

Meg specialises in US corporate and securities law, advising on, among other things, general corporate matters and venture capital financing transactions, particularly in the life sciences sector. 

Meg's day-to-day work focuses on advising life sciences and technology companies at all stages of development, with a particular focus on advising both companies and investors in venture capital financing transactions, from early-stage to late-stage. She also works closely with entrepreneurs to counsel them through initial company formation issues, day-to-day corporate governance matters, and liquidity events.

Prior to joining Taylor Wessing, she spent ten years at a top-tier firm in California, where she represented prominent US and international companies and funds in life sciences and technology financing transactions and exits. She is a current member of the California Bar.

Meg particularly enjoys advising clients on complex US and cross-border venture financing transactions.

Expertise

Services and Groups

Venture capital
Corporate/M&A & capital markets
General corporate
M&A
Financing rounds (Seed, subsequent and growth financing) equity and non-equity instruments
Start-up advice

Sectors

Life sciences & healthcare
Biotech
Life sciences start-ups and investors
Medical devices
Pharmaceuticals
Our USA offering

Over the past 10 years, we've built a trusted legal team in San Francisco, focused on technology, media and communciation, life sciences and healthcare, real estate, private wealth, and private equity. Supported by colleagues in the UK and Europe, we also offer deep expertise in M&A, international growth, commercial deals, and data privacy.

Find out more

CV

Since 2024 Senior Counsel, Taylor Wessing
2014 - 2024 Associate, Wilson Sonsini Goodrich & Rosati, PC, San Diego, California, USA
2014 Admission to bar, California, USA
2013 Juris Doctor, Indiana University Maurer School of Law, Bloomington, IN, USA
2010 Bachelor of Science, Clemson University, Clemson, SC, USA

Career

Since 2024 Senior Counsel, Taylor Wessing
2014 - 2024 Associate, Wilson Sonsini Goodrich & Rosati, PC, San Diego, California, USA

Education

2014 Admission to bar, California, USA
2013 Juris Doctor, Indiana University Maurer School of Law, Bloomington, IN, USA
2010 Bachelor of Science, Clemson University, Clemson, SC, USA

Experience

Series B fundraising of USD100+ million

Represented client utilizing a generated AI discovery platform in oversubscribed financing round with multiple strategic and institutional investors

Meg Burton

Series C fundraising of USD200 million

Represented U.S. medical imaging software and device company in late-stage financing round

Meg Burton

Meg's news & insights

View Meg's insights
Inside the Office Building
Click here to find out more
Corporate/M&A & capital markets

Advising on Sona's US$45 million Series B funding

8 April 2026

by multiple authors

Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Advising Waivgen on its acquisition by Synechron

21 October 2025

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Artificial intelligence

Advising Artificial Societies on Pre-Seed and Seed funding rounds

3 September 2025

by multiple authors

Click here to find out more
View Meg's insights

Related news & insights

FinTech Stories
Fintech

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

22 April 2026

by Miroslav Đurić, LL.M.

Click here to find out more
ivdr mdr
Medical devices

Proposed Amendments to the EU Medical Device Regulation

15 April 2026
Briefing

by Bartosz Świdrak

Click here to find out more
biotech helix
Biotech

Impact of the new Biotech Act on Clinical Trials in the EU

15 April 2026
Quick read

by Irina Rebin

Click here to find out more
Life sciences & healthcare

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

15 April 2026
Briefing

by Irina Rebin

Click here to find out more
Road Marking
Corporate/M&A & capital markets

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

14 April 2026

by Paul Thorpe and Jack Coventry

Click here to find out more
Flag of the European community
Life sciences & healthcare

Life Sciences Legal Lens – Vol. 1

7 April 2026
Click here to find out more

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

1 April 2026

by multiple authors

Click here to find out more
International life sciences
Artificial intelligence

Hungary opens health data infrastructure for AI development

1 April 2026
Briefing

by János Kopasz, AIGP, CIPP/E, CIPM

Click here to find out more
International life sciences
Medical devices

No claim for damages as a result of participation in clinical drug trials

1 April 2026

by Irina Rebin

Click here to find out more
International life sciences
Life sciences & healthcare

Ban on “social egg freezing” declared unconstitutional

1 April 2026
Quick read

by Christopher Bakier

Click here to find out more
View all insights

Related people

UK
Global

Clover May

Associate

London
+44 20 7300 7000
Email me
View profile
Tom Charnley

Tom Charnley

Senior Counsel

Liverpool
London
+44 20 7300 7000
Email me
View profile
Joshua Gertner

Joshua Gertner

Senior Associate

London
+44 20 7300 7000
Email me
View profile
James Homan

James Homan

Partner

London
+44 20 7300 4124
Email me
View profile
Ross McNaughton

Ross McNaughton

Partner

Cambridge
+44 1223 446 443
Email me
View profile
Rachael Potts

Rachael Roberts

Associate

London
+44 20 7300 7000
Email me
View profile
Claire Matthews

Claire Matthews

Partner

London
+44 20 7300 7023
Email me
View profile
Tunc Ilgin

Tunç Ilgin

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Phoebe Sennett

Phoebe Sennett

Associate

London
+44 20 7300 7000
Email me
View profile
Ian Moore

Ian Moore

Partner

London
+44 20 7300 4664
Email me
View profile
Full team
Tom Charnley

Tom Charnley

Senior Counsel

Liverpool
London
+44 20 7300 7000
Email me
View profile

Ben Eaves

Associate

London
+44 20 7300 7000
Email me
View profile
Jan Riebeling

Dr. Jan Riebeling

Partner

Hamburg
+49 40 36803 0
Email me
View profile
Dannie Hanna

Dannie Hanna

Partner

Dublin
+353 87 906 0334
Email me
View profile
Alisa Mathes

Alisa Mathes-Salathe

Senior Associate

Frankfurt
+49 69 97130 0
Email me
View profile
Ian Moore

Ian Moore

Partner

London
+44 20 7300 4664
Email me
View profile
James Homan

James Homan

Partner

London
+44 20 7300 4124
Email me
View profile
Sam Peters

Sam Peters

Senior Associate

Eindhoven
+31 88 02 43 179
Email me
View profile
Bhavna Pattanaik

Bhavna Pattanaik

Senior Associate

London
+44 20 7300 7000
Email me
Zabdaj Pollen

Zabdaj Pollen

Partner

Eindhoven
+31 88 02 43 050
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing